Meet Keytruda, the Israeli drug for fighting metastatic melanoma. If this new treatment known as immunotherapy lives up to expectations, the world of oncology will undergo a real treatment revolution within just a few years.
By Sarit Rosenblum
At the age of 68, Prof. Ben-Shabbat noticed an odd-looking sore on his head. “They told me at the hospital that it’s a melanoma and needs to be surgically removed,” he relates. “After the operation, I said to myself, thank God it’s gone.” But the sore reappeared, on his neck this time. The doctors informed Ben-Shabbat and his family that they were dealing with a metastatic growth, and that Ben-Shabbat’s future looked bleak. Continue Reading »